Also, cancer-related p53 mutations increase the pentose phosphate flux by avoiding p53 binding to glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme of the pentose phosphate pathway (PPP) (Jiang P. et al., 2011). The gene discussed is TP53; the disease is cancer.